Coagulation and Fibrinolytic QA Flashcards
1
Q
1. Which of the following initiates in vivo coagulation by activation of factor VII? A. Protein C B. Tissue factor C. Plasmin activator D. Thrombomodulin
A
B
2
Q
2. Which of the following clotting factors plays a role in clot formation in vitro, but not in vivo? in vitro clot formation and not in vivo coagulation? A. VIIa B. IIa C. XIIa D. Xa
A
C
3
Q
- The anticoagulant of choice for most routine
coagulation studies is:
A. Sodium oxalate
B. Sodium citrate
C. Heparin
D. Ethylenediaminetetraacetic acid (EDTA)
A
B
4
Q
4. Which ratio of anticoagulant-to-blood is correct for coagulation procedures? A. 1:4 B. 1:5 C. 1:9 D. 1:10
A
C
5
Q
- Which results would be expected for the
prothrombin time (PT) and activated partial
thromboplastin time (APTT) in a patient with
polycythemia?
A. Both prolonged
B. Both shortened
C. Normal PT, prolonged APTT
D. Both normal
A
A
6
Q
6. What reagents are used in the PT test? A. Thromboplastin and sodium chloride B. Thromboplastin and potassium chloride C. Thromboplastin and calcium D. Actin and calcium chloride
A
c
7
Q
7. Which test would be abnormal in a patient with factor X deficiency? A. PT only B. APTT only C. PT and APTT D. Thrombin time
A
c
8
Q
8. Which clotting factor is not measured by PT and APTT tests? A. Factor VIII B. Factor IX C. Factor V D. Factor XIII
A
D
9
Q
9. A modification of which procedure can be used to measure fibrinogen? A. PT B. APTT C. Thrombin time D. Fibrin degradation products
A
c
10
Q
- Which of the following characterizes vitamin K?
A. It is required for biological activity of fibrinolysis
B. Its activity is enhanced by heparin therapy
C. It is required for carboxylation of glutamate residues of some coagulation factors
D. It is made by the endothelial cells
A
c
11
Q
- Which statement about the fibrinogen/fibrin degradation product test is correct?
A. It detects early degradation products (X and Y)
B. It is decreased in disseminated intravascular coagulation (DIC)
C. It evaluates the coagulation system
D. It detects late degradation products (D and E)
A
d
12
Q
12. Which of the following clotting factors are measured by the APTT test? A. II, VII, IX, X B. VII, X, V, II, I C. XII, XI, IX, VIII, X, V, II, I D. XII, VII, X, V, II, I
A
C
13
Q
13. Which coagulation test(s) would be abnormal in a vitamin K–deficient patient? A. PT only B. PT and APTT C. Fibrinogen level D. Thrombin time
A
b
14
Q
- Which of the following is referred to as an
endogenous activator of plasminogen?
A. Streptokinase
B. Transamidase
C. Tissue plasminogen activator
D. Tissue plasminogen activator inhibitor
A
c
15
Q
16. Which protein is the primary inhibitor of the fibrinolytic system? A. Protein C B. Protein S C. α2-Antiplasmin D. α2-Macroglobulin
A
c